Loading clinical trials...
Loading clinical trials...
Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease
Conditions
Interventions
OMS643762
Placebo
Locations
9
United States
San Diego, California, United States
Englewood, Colorado, United States
Gainesville, Florida, United States
Tampa, Florida, United States
Baltimore, Maryland, United States
New York, New York, United States
Start Date
January 1, 2014
Primary Completion Date
October 15, 2014
Completion Date
October 15, 2014
Last Updated
October 22, 2018
NCT02855476
NCT01574053
NCT04120493
NCT05107128
NCT03664804
NCT00670709
Lead Sponsor
Omeros Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions